electroCore (ECOR) EBIT Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn | -39.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.09% |
| Dec 31, 2025 | 4.23% |
| Sep 30, 2025 | -8.79% |
| Jun 30, 2025 | -35.31% |
| Mar 31, 2025 | 0.70% |
| Dec 31, 2024 | 22.41% |
| Sep 30, 2024 | 35.75% |
| Jun 30, 2024 | 48.06% |
| Mar 31, 2024 | 37.89% |
| Dec 31, 2023 | 33.11% |
| Sep 30, 2023 | 25.74% |
| Jun 30, 2023 | 14.30% |
| Mar 31, 2023 | -11.04% |
| Dec 31, 2022 | -8.13% |
| Sep 30, 2022 | -39.42% |
| Jun 30, 2022 | -11.88% |
| Mar 31, 2022 | -3.66% |
| Dec 31, 2021 | 13.46% |
| Sep 30, 2021 | 11.22% |
| Jun 30, 2021 | 12.18% |
| Mar 31, 2021 | 32.81% |
| Dec 31, 2020 | 26.52% |
| Sep 30, 2020 | 58.80% |
| Jun 30, 2020 | 52.15% |
| Mar 31, 2020 | 43.61% |
| Dec 31, 2019 | 45.12% |
| Sep 30, 2019 | 19.61% |
| Jun 30, 2019 | 23.68% |
| Mar 31, 2019 | -56.18% |
| Dec 31, 2018 | -109.50% |
| Sep 30, 2018 | -126.32% |
| Jun 30, 2018 | -118.30% |